lisaanson_web

Lisa Anson appointed as president of AstraZeneca’s UK marketing

pharmafile | December 15, 2011 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Lisa Anson 

AstraZeneca has appointed Lisa Anson as its new president for the firm’s UK marketing company, effective 1 January 2012. 

Anson takes over the UK presidency from Mark Jones, who will take on the new role of area vice president for southern Europe and Israel. 

She brings a high level of experience from across AstraZeneca’s global business, and comes to her new role after working as vice president of emerging brands within the firm’s global marketing and sales operations.  

Anson joined AstraZeneca in the US, following experience working in US cancer care centres and disease management and has a background in strategy consulting. 

Advertisement

In her new role Anson will be looking to build stronger ties with the NHS and deal with issues of market access.

She will also take charge of AstraZeneca’s entire UK sales force, as well as a sales and marketing team based in Luton and a clinical research group in Edinburgh.

Related Content

Astra Zeneca Logo

NICE recommends Benralizumab for Rare Form of Vasculitis

The National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s benralizumab (Fasenra) as …

NICE approves AstraZeneca’s dual immunotherapy for advanced liver cancer

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence …

Astra Zeneca Logo

Purpose and people: the enduring power of brand and the evolution of employer identity

Two decades ago, terms like purpose and people were rarely at the forefront of branding …

The Gateway to Local Adoption Series

Latest content